Details for Patent: 10,973,806
Which drugs does patent 10,973,806 protect, and when does it expire?
Patent 10,973,806 protects FYARRO and is included in one NDA.
This patent has fifty patent family members in twenty-seven countries.
Summary for Patent: 10,973,806
| Title: | Methods of treating epithelioid cell tumors comprising administering a composition comprising nanoparticles comprising an mTOR inhibitor and an albumin |
| Abstract: | The present invention provides methods and compositions for treating epithelioid cell tumors (such as a PEComa) by administering a composition comprising nanoparticles comprising an mTOR inhibitor and an albumin. |
| Inventor(s): | Neil P. Desai |
| Assignee: | Abraxis Bioscience LLC |
| Application Number: | US15/737,936 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 10,973,806
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aadi | FYARRO | sirolimus | POWDER;INTRAVENOUS | 213312-001 | Nov 22, 2021 | RX | Yes | Yes | 10,973,806 | ⤷ Start Trial | TREATMENT OF ADULT PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE OR METASTATIC MALIGNANT PERIVASCULAR EPITHELIOID CELL TUMOR (PECOMA) WITH A DOSE BETWEEN ABOUT 56 MG/M2 AND ABOUT 100 MG/M2 ADMINISTERED ON DAYS 1 AND 8 OF A 21-DAY CYCLE | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,973,806
| PCT Information | |||
| PCT Filed | June 29, 2016 | PCT Application Number: | PCT/US2016/040170 |
| PCT Publication Date: | January 05, 2017 | PCT Publication Number: | WO2017/004249 |
International Family Members for US Patent 10,973,806
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2016285720 | ⤷ Start Trial | |||
| Australia | 2021286245 | ⤷ Start Trial | |||
| Brazil | 112017027954 | ⤷ Start Trial | |||
| Canada | 2990693 | ⤷ Start Trial | |||
| Chile | 2017003456 | ⤷ Start Trial | |||
| China | 108024999 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
